We are live on ! Find out more
Calamos Advisors

Calamos Advisors Portfolio holdings

AUM $28.2B
1-Year Est. Return 21.78%
This Fund
S&P 500
This Quarter Est. Return
+7.67%
1 Year Est. Return
+21.78%
3 Year Est. Return
+69.57%
5 Year Est. Return
+92%
10 Year Est. Return
+282.63%
AUM
$26.7B
AUM Growth
+$3.85B
Cap. Flow
-$4.59B
Cap. Flow %
-17.17%
Top 10 Hldgs %
20.41%
Holding
1,231
New
232
Increased
271
Reduced
149
Closed
114
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BMAC.U
676
DELISTED
Black Mountain Acquisition Corp. Units, each consisting of one share of Class A common stock and three quarters of one warrant
BMAC.U
$2.29M 0.01%
+225,500
New +$2.29M
VRAY
677
DELISTED
ViewRay, Inc.
VRAY
$2.29M 0.01%
414,893
-9,392
-2% -$57.2K
BLFS icon
678
BioLife Solutions
BLFS
$1.56B
$2.29M 0.01%
61,337
+24,558
+67% +$1.05M
ITUB icon
679
Itaú Unibanco
ITUB
$91.6B
$2.26M 0.01%
682,194
-1,054,404
-61% -$3.8M
IWB icon
680
iShares Russell 1000 ETF
IWB
$47.9B
$2.23M 0.01%
8,442
+7,503
+799% +$1.93M
EGGF.U
681
DELISTED
EG Acquisition Corp. Units, each consisting of one share of Class A common stock and one-third of one redeemable warrant
EGGF.U
$2.23M 0.01%
+225,000
New +$2.23M
MACC.U
682
DELISTED
Mission Advancement Corp. Units, each consisting of one share of Class A Common Stock and one-third of one Redeemable Warrant
MACC.U
$2.23M 0.01%
225,000
IFF icon
683
International Flavors & Fragrances
IFF
$20.2B
$2.21M 0.01%
14,697
+569
+4% +$82.9K
ITQRU
684
DELISTED
Itiquira Acquisition Corp. Unit
ITQRU
$2.19M 0.01%
220,000
YETI icon
685
Yeti Holdings
YETI
$3.93B
$2.19M 0.01%
26,404
-29,092
-52% -$2.67M
CPRI icon
686
Capri Holdings
CPRI
$1.88B
$2.18M 0.01%
33,650
-4,500
-12% -$266K
SSYS icon
687
Stratasys
SSYS
$690M
$2.18M 0.01%
+88,916
New +$2.48M
ODFL icon
688
Old Dominion Freight Line
ODFL
$47.1B
$2.17M 0.01%
12,128
VELOU
689
DELISTED
Velocity Acquisition Corp. Units
VELOU
$2.15M 0.01%
210,000
DRVN icon
690
Driven Brands
DRVN
$2.47B
$2.14M 0.01%
63,570
-13,451
-17% -$421K
GLBLU
691
DELISTED
Cartesian Growth Corporation Unit
GLBLU
$2.13M 0.01%
210,000
SPKBU
692
DELISTED
Silver Spike Acquisition Corp II Units
SPKBU
$2.07M 0.01%
208,021
FWAC
693
DELISTED
Fifth Wall Acquisition Corp. III Class A Ordinary Shares
FWAC
$2.06M 0.01%
206,711
ACDI.U
694
DELISTED
Ascendant Digital Acquisition Corp. III Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant
ACDI.U
$2.03M 0.01%
+200,100
New +$2.02M
ICNC.U
695
DELISTED
Iconic Sports Acquisition Corp. Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant
ICNC.U
$2.02M 0.01%
+200,000
New +$2.03M
GLTA.U
696
DELISTED
Galata Acquisition Corp. Units, each consisting of one class A ordinary share and one-half of one warrant
GLTA.U
$2.02M 0.01%
200,000
LIONU
697
DELISTED
Lionheart III Corp Unit
LIONU
$2.01M 0.01%
+200,000
New +$2.01M
BRIVU
698
DELISTED
B. Riley Principal 250 Merger Corp. Units
BRIVU
$2M 0.01%
200,000
RMGCU
699
DELISTED
RMG Acquisition Corp. III Unit
RMGCU
$1.99M 0.01%
200,000
CLRMU
700
DELISTED
Clarim Acquisition Corp. Unit
CLRMU
$1.99M 0.01%
200,000

Similar funds

Calamos Advisors's Q4 2021 Portfolio in Review

As of Q4 2021, Calamos Advisors held 1,231 positions worth $26.7B, up 17% from $22.9B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Calamos Advisors withdrew a net $4.59B in Q4 2021, closing 114 positions and reducing 149 holdings. Its most notable exit was AstraZeneca, an estimated $17.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Calamos Advisors opened a new position in Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A worth $169M.

  • Calamos Advisors's largest Q4 2021 buy was Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A: 81,590 shares worth $169M.
  • Calamos Advisors added most to State Street SPDR S&P 500 ETF Trust in Q4 2021, an estimated $151M increase.
  • Calamos Advisors's biggest Q4 2021 reduction was JPMorgan Chase, cutting an estimated $29.5M.
  • Calamos Advisors fully exited AstraZeneca in Q4 2021, selling an estimated $17.8M.
  • Calamos Advisors's ten largest holdings make up 20% of its $26.7B portfolio in Q4 2021.
  • Calamos Advisors opened 232 new positions and closed 114 in Q4 2021.
  • Calamos Advisors's portfolio value rose 17% quarter-over-quarter to $26.7B.

Based on Calamos Advisors's 13F filing for Q4 2021, filed 1 Feb 2022.